BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  VBI Vaccines Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5M

  The pricing for the underwritten public offering was for a total number of 14,000,000 common shares for expected gross proceeds of US$42.7 million

  October 26, 2017

   · 

  5 min read
• 

  Deals

  Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of Dimension

  Ultragenyx and Dimension struck the m&a deal on October 2, 2017,

  October 26, 2017

   · 

  6 min read
• Business

  ReWalk Robotics to Report Third Quarter 2017 Financial Results on November 2, 2017

  ReWalk’s CEO and CFO will host a conference call to discuss the results.

  October 26, 2017

   · 

  1 min read
• Drug Development

  Omeros Reports Additional and Consistently Positive Data for OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

  Omeros today announced further positive data from the company’s ongoing Phase II study of OMS721 evaluating patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy.

  October 26, 2017

   · 

  10 min read
• Drug Development

  Transgene: First Patient Treated in a Phase I/IIa Trial (Oncovirac) of Novel Oncolytic Virus TG6002 in Recurrent Glioblastoma

  The first patient with recurrent glioblastoma has been treated in the first-in-human clinical trial of TG6002, a novel oncolytic virus.

  October 26, 2017

   · 

  7 min read
• Biotech Beach

  CureDuchenne Launches Virtual Durable Medical Equipment Expo for the Duchenne Community

  CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, launched the CureDuchenne Cares Virtual Durable Medical Equipment (DME) Expo as a resource for the Duchenne community.

  October 26, 2017

   · 

  2 min read
• Business

  M2Gen Announces BMS’ Participation in ORIEN Avatar Research Program

  M2Gen announced today that Bristol-Myers Squibb has joined the Oncology Research Information Exchange Network Avatar Research Program.

  October 26, 2017

   · 

  2 min read
• Business

  Recordati: Very Good Results In The First Nine Months 2017. Continued Growth In Sales +11.8%, Operating Income +21.8%, Net Income +20.6%. Interim Dividend € 0.42 (+20%)

  These financial statements will be available today at the company’s offices and on the company’s website.

  October 26, 2017

   · 

  12 min read
• Business

  Integra LifeSciences Reports Third Quarter 2017 Financial Results

  Total revenues for the third quarter were $278.8 million, reflecting an increase of $28.5 million, or 11.4%, over the third quarter of 2016.

  October 26, 2017

   · 

  21 min read
• Essilor: Capital Increase Reserved for Employees Outside France

  Employee shareholding is central to Essilor’s history, identity and culture.

  October 26, 2017

   · 

  4 min read